Unmethylated Glioblastoma

Oncology·MeSH: Glioblastoma

Prevalence

3.2 / 100K

Incidence

3.2 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Unmethylated Glioblastoma?

There are 1 clinical trial targeting Unmethylated Glioblastoma tracked by BioSniper.

What is the prevalence of Unmethylated Glioblastoma?

The estimated prevalence of Unmethylated Glioblastoma is approximately 3.2 per 100,000 population.

Deep-dive into Unmethylated Glioblastoma

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Unmethylated Glioblastoma — Drugs in Development & Clinical Trials | BioSniper